a public good project by the
Synthesis
Company
of California

© 2026

P. Drings | doi.page

0 works0 citations0 h-index

P. Drings

Publications by Year

Research Areas

Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Neuroendocrine Tumor Research Advances, Cancer Treatment and Pharmacology

Most-Cited Works

→ Cancer-Related Anemia: Pathogenesis, Prevalence and Treatment(2005)224 cited
→ New aspects in the staging of lung cancer. Prospective validation of the international union against cancer TNM classification(1992)205 cited
→ Coping, Distress, and Survival Among Patients With Lung Cancer(1999)197 cited
→ Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas(1998)178 cited
→ hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lung cancer susceptibility in a caucasian population(2000)162 cited
→ Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): The role of sex as a predictor for survival(1991)146 cited

→ Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.(1997)

142 cited

→ Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer(1997)114 cited

→ Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma(1985)105 cited

→ Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility(2001)103 cited